Financhill
Back

Greenlight Capital Re Ltd. Vs. Lyell Immunopharma, Inc. Industry Stock Comparison

Buy
62

GLRE
Greenlight Capital Re Ltd.

Last Price:
$14.73
Seasonality Move:
-0.18%
Buy
61

LYEL
Lyell Immunopharma, Inc.

Last Price:
$37.17
Seasonality Move:
-16.78%
Buy
62
Greenlight Capital Re Ltd. (GLRE) is a Buy

Is Greenlight Capital Re Ltd. a Buy, Sell or Hold?

  • The current Greenlight Capital Re Ltd. [GLRE] share price is $14.72. The Score for GLRE is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • GLRE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
Lyell Immunopharma, Inc. (LYEL) is a Buy

Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?

  • The current Lyell Immunopharma, Inc. [LYEL] share price is $37.33. The Score for LYEL is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • LYEL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GLRE Stock Price Chart

What is Greenlight Capital Re Ltd.'s stock price today?

  • The Greenlight Capital Re Ltd. share price today is $14.72
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GLRE is experiencing slight buying pressure.

LYEL Stock Price Chart

What is Lyell Immunopharma, Inc.'s stock price today?

  • The Lyell Immunopharma, Inc. share price today is $37.33
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing selling pressure, which indicates risk of future bearish movement.

GLRE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.43 Buy
Relative Strength Index (14 RSI): 74.1 Buy
Chaikin Money Flow: 36773 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.12 - 14.36) Buy
Bollinger Bands (100): (12.33 - 13.57) Buy

LYEL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.24 Buy
Relative Strength Index (14 RSI): 78.97 Buy
Chaikin Money Flow: -246560 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.8 - 33.24) Buy
Bollinger Bands (100): (10.76 - 24.28) Buy

GLRE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.46 Buy
20-day SMA: 13.96 Buy
50-day SMA: 13.11 Buy
200-day SMA: 13.29 Buy
8-day EMA: 14.42 Buy
20-day EMA: 14.01 Buy
50-day EMA: 13.45 Buy
200-day EMA: 13.25 Buy

LYEL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34 Buy
20-day SMA: 29.06 Buy
50-day SMA: 22.08 Buy
200-day SMA: 13.64 Buy
8-day EMA: 33.98 Buy
20-day EMA: 29.78 Buy
50-day EMA: 23.99 Buy
200-day EMA: 17.62 Buy

Greenlight Capital Re Ltd. Earnings Growth & GLRE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.86 per share, and a decrease next year of $3.96 per share.

Greenlight Capital Re Ltd. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Lyell Immunopharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):